Dr. Reddy's Laboratories Limited RDY
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -10.48% | -6.73% | -1.06% | 6.73% | 10.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.48% | -6.73% | -1.06% | 6.73% | 10.65% |
| Cost of Revenue | 3.78% | 9.55% | 12.43% | 17.52% | 18.37% |
| Gross Profit | -21.48% | -18.67% | -10.62% | -0.68% | 5.35% |
| SG&A Expenses | 3.29% | 6.64% | 8.83% | 9.97% | 12.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 50.54% | -25.36% | -51.36% | -133.67% | -120.14% |
| Total Operating Expenses | 2.24% | 5.29% | 7.62% | 10.84% | 13.18% |
| Operating Income | -58.68% | -50.77% | -31.59% | -7.52% | 2.01% |
| Income Before Tax | -56.91% | -48.77% | -30.87% | -3.63% | 2.27% |
| Income Tax Expenses | -60.37% | -58.12% | -38.67% | -11.90% | -3.67% |
| Earnings from Continuing Operations | -55.85% | -45.57% | -28.20% | -0.85% | 4.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.96% | 158.23% | 152.04% | 156.51% | 139.22% |
| Net Income | -55.47% | -44.32% | -26.64% | 1.37% | 6.56% |
| EBIT | -58.68% | -50.77% | -31.59% | -7.52% | 2.01% |
| EBITDA | -46.45% | -39.37% | -23.29% | -3.19% | 5.54% |
| EPS Basic | -55.47% | -44.31% | -26.59% | 1.40% | 6.56% |
| Normalized Basic EPS | -57.76% | -48.31% | -28.88% | -1.35% | 5.04% |
| EPS Diluted | -55.45% | -44.26% | -26.54% | 1.46% | 6.58% |
| Normalized Diluted EPS | -57.75% | -48.27% | -28.83% | -1.27% | 5.12% |
| Average Basic Shares Outstanding | 0.04% | 0.03% | -0.03% | -0.03% | 0.01% |
| Average Diluted Shares Outstanding | -0.02% | -0.05% | -0.10% | -0.09% | -0.04% |
| Dividend Per Share | -5.41% | -5.41% | -5.41% | -4.05% | -4.05% |
| Payout Ratio | 1.05% | 0.72% | 0.31% | -0.05% | -0.10% |